MedPath

The functions of antidiabetic drugs sulphonylurea in a particular gene mutation patients in chhatisgarh diabetes patients

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2021/09/036219
Lead Sponsor
ALL INDIA INSTITUTE OF MEDICAL SCIENCES RAIPUR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Either gender diagnosed with Type 2 Diabetic Mellitus.

2. 18-75 years of age.

3. Uncontrolled blood glucose level in spite of exercise dietary goals plus on metformin monotherapy.

4. Treatment naïve patient with HbA1c<=10 % with altered fasting and post prandial glucose.

Exclusion Criteria

1. Type 1 Diabetes mellitus.

2. Pregnant & lactating women.

3. Type 2 Diabetic Mellitus patients on insulin or on OADs other than metformin and sulphonylureas.

4. Patients with HbA1c <7 or > 10%.

5. Patients who are allergic to drugs containing sulfa component in their chemical structure.

6. Patients who are suffering with end stage systemic diseases.

7. Patients in Intensive Care Unit (ICU).

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.